1. Cancer is not a single disease: is it safe to extrapolate evidence from trials of direct oral anticoagulants in cancer‐associated venous thromboembolism to patients with haematological malignancies?. (22nd February 2021) Authors: Buka, Richard J.; Chandra, Deepak; Sutton, David J. Journal: British journal of haematology Issue: Volume 193:Number 1(2021) Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Heterozygous, germline JAK2 E846D substitution as the cause of familial erythrocytosis. (28th June 2022) Authors: Tun, Phyo Wint Wint; Buka, Richard J.; Graham, Jane; Dyer, Peter Journal: British journal of haematology Issue: Volume 198:Number 5(2022) Page Start: 923 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. How will UK hospitals use andexanet alfa? A review of local protocols. Issue 1 (24th January 2023) Authors: Glancy, Paula; Sutton, David J.; Gomez, Keith; Nicolson, Phillip L. R.; Buka, Richard J. Journal: EJHaem Issue: Volume 4:Issue 1(2023) Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗